(From left) Shyam Sunder Singh, MD &CEO, Septalyst receiving CIMS Healthcare Excellence Award for “Fastest Growing Company of the year in Nephrology” from BJP leader Parag Alwani along with his team. |
Mumbai, July 25, 2017: Septalyst Lifesciencs Pvt. Ltd., a Mumbai based super-speciality pharmaceutical company focusing on Nephro, Neuro & Critical care products & therapy has bagged the award for “Fastest Growing Company of the year in Nephrology” at the seventh edition of CIMS Healthcare Excellence Awards held in Mumbai.
Speaking about the award, Shyam Sunder Singh, MD & CEO, Septalyst said, “It is indeed a moment of pride & pleasure to be recognized for our good work. I dedicate this award to my team for their hard work & commitment. We are now even more motivated to work with missionary zeal and commitment and achieve bigger heights in future. Unique products, very strong sales team and focus on secondary sales are the main factors which led to very rapid growth of the company.”
Septalyst started its operations in 2010 and in a short span of time has carved a niche in Nephro & Critical care segments. Today, it is the fastest growing company in the field of Nephrology & ranked amongst the top 12 players in Indian Nephrology. With a team size of 200 highly talented professionals, a strong network of 30 sales depot & 150 stockists across India, it is all set for rapid growth & expansion.
Recently Septalyst launched Central Nervous System (CNS) division in 10 states with 18 products in Neuro & psychiatry range. By December 2017, it plans to have a pan India presence in CNS with a field force of 250 people. Septalyst is confident that with its therapy centric business model, professional work culture & motivated sales force, it will soon become a leading player in the CNS segment also.
The company is promoted by young entrepreneurs having wide experience & exposure in exports & domestic pharmaceutical industry. Founder Director Shyam Sunder Singh has a vast experience of 20 years in retail, supply chain & pharmaceutical industry.